Ronald Rapini, MD
Basic profileThe University of Texas Health Science Center at Houston
Ronald Rapini is a Dermatology physician affiliated with The University of Texas Health Science Center at Houston. OpenAlex indexes 267 publications with 5,346 citations (h-index 35). By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6500 West Loop S
Bellaire, TX 774013536
Telephone
713-500-8260Provider last certified this registry record 16 Dec 2025.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20254 payments
- Janssen Biotech, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
29.8%Azole Antifungal11.5%Ketoconazole100%Part D≥49 patientsTetracycline-class Drug8.3%Doxycycline Monohydrate41%Doxycycline Hyclate37%Minocycline Hcl22%Part D<11 patients+ 3 more classes in this area
Dermatology
27.4%Corticosteroid19.1%Triamcinolone Acetonide100%Part D≥70 patientsInterleukin-4 Receptor alpha Antagonist4%Dupixent Pen100%Part D<11 patients+ 2 more classes in this area
Sensory organs
22.2%Corticosteroid22.2%Hydrocortisone48%Clobetasol Propionate43%Betamethasone Dipropionate8%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Diverse types of dermatologic toxicities from immune checkpoint blockade therapy
Journal of Cutaneous Pathology
2016 - Emerging clinical applications of selected biomarkers in melanoma
Clinical Cosmetic and Investigational Dermatology
2015
Similar KOLs
Other experts from the same institution or the same specialty.
John Reveille, MD
The University of Texas Health Science Center at Houston
Martin Citardi, MD
The University of Texas Health Science Center at Houston
Frank Arnett, MD
The University of Texas Health Science Center at Houston
Jerry Wolinsky, MD
The University of Texas Health Science Center at Houston
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”